Fraunhofer and EUROIMMUN join forces to combat COVID-19

Mass production of COVID-19 test systems

Press release / April 09, 2020

EUROIMMUN AG is one of the first European diagnostics companies to offer CE-marked antibody detection systems to support COVID-19 diagnostics. These tests can be used to identify people who have already come into con-tact with the virus. This is important since it offers a means of tracking down individuals who have already recovered from the infection and are thus highly likely to have developed immunity to a repeat infection with SARS-CoV-2. The Fraunhofer Research Institution for Marine Biotechnology and Cell Technology EMB in Lübeck, Germany, is supporting EUROIMMUN AG in its efforts to scale up the production of the new serological test systems for COVID-19 diagnos-tics to the levels required for large-scale, mass-market deployment.